Welcome to Hubei Haosun Pharmaceutical Co.,Ltd.
Home| Order | Contact us
News

Pass EDQM Audit

Audit time: on August 21 to 23, 2024

After three days of EDQM and AFMPS audit, our five API products Docetaxel anhydrous, Amisulpride, Granisetron Hydrochloride, Flumazenil and Irinotecan Hydrochloride approved by EDQM, and got an EUGMP certificate for API Granisetron Hydrochloride